Aurobindo receives FDA approval for phenoxybenzamine hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application phenoxybenzamine hydrochloride capsules 10mg.